8-K - Camp4 Therapeutics Corp (0001736730) (Filer)

10-Q - Camp4 Therapeutics Corp (0001736730) (Filer)

8-K - Camp4 Therapeutics Corp (0001736730) (Filer)

S-8 - Camp4 Therapeutics Corp (0001736730) (Filer)

8-K - Camp4 Therapeutics Corp (0001736730) (Filer)

424B4 - Camp4 Therapeutics Corp (0001736730) (Filer)

EFFECT - Camp4 Therapeutics Corp (0001736730) (Filer)

CERT - Camp4 Therapeutics Corp (0001736730) (Filer)

8-A12B - Camp4 Therapeutics Corp (0001736730) (Filer)

S-1/A - Camp4 Therapeutics Corp (0001736730) (Filer)

CAMBRIDGE, Mass., Jan. 13, 2025 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation ("CAMP4") (NASDAQ:CAMP), a clinical-stage biotechnology company developing regRNA-targeting antisense oligonucleotide (ASO) therapies to upregulate gene expression to restore healthy protein levels, today announced that Josh Mandel-Brehm, President & CEO, will present a corporate update at the 43rd Annual J.P. Morgan Healthcare Conference taking place in San Francisco, California, on Wednesday, January 15, 2025, at 3:45 p.m. PST. The event will be webcast live and can be accessed on the investor relations page of CAMP4's website at www.investors.camp4tx.com. A replay of the webcast will be archived on the C

Data from Single Ascending Dose (SAD) portion of Phase 1 study of CMP-CPS-001 for the treatment of urea cycle disorders (UCDs) demonstrates favorable safety resultsCompleted dosing in the first two Multiple Ascending Dose (MAD) cohorts, and initiated dosing in Cohort 3MAD safety and key study biomarker data expected in 2H 2025CAMP4 added to Russell 2000® IndexInitiation of new discovery program targeting a GBA1 regRNA for the treatment of Parkinson's disease (PD)Company to present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15 at 3:45 p.m. PST CAMBRIDGE, Mass., Jan. 07, 2025 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation ("CAMP4") (NASDAQ:CAMP), a clinic

CAMBRIDGE, Mass., Dec. 10, 2024 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation ("CAMP4") (NASDAQ:CAMP), a clinical-stage biotechnology company developing a pipeline of regRNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels across a range of genetic diseases, today announced the appointments of John Maraganore, Ph.D., and Rachel Meyers, Ph.D., as strategic advisors to the Company. For nearly 20 years, Dr. Maraganore served as the founding Chief Executive Officer and Director of Alnylam where he led the company's programs in RNA interference through global commercialization, resulting in the launch of the first four RNAi th

CAMBRIDGE, Mass., Dec. 02, 2024 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation ("CAMP4") (NASDAQ:CAMP), a clinical-stage biotechnology company developing a pipeline of regRNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels across a range of genetic diseases, today announced that management will present and be available for one-on-one meetings at the Piper Sandler 36th Annual Healthcare Conference to be held at the Lotte New York Palace Hotel in New York City December 3rd – 5th, 2024. Piper Sandler 36th Annual Healthcare Conference Presentations Date:December 5, 2024  Time:1:00-1:25 PM ET  Webcast Link:Click Here   A li

- Completed Initial Public Offering (IPO) of common stock, raising gross proceeds of $82.1M- Single Ascending Dose (SAD) portion of Phase 1 study of CMP-CPS-001 completed; safety data anticipated in Q1 2025- Entered strategic research collaboration with BioMarin valued at over $370M CAMBRIDGE, Mass., Nov. 21, 2024 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation ("CAMP4") (NASDAQ:CAMP), a clinical-stage biotechnology company developing a pipeline of regRNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels across a range of genetic diseases, today reported financial results for the third quarter ended September 30, 2024, and p

CAMBRIDGE, Mass., Oct. 10, 2024 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation ("CAMP4") (NASDAQ:CAMP), a clinical-stage biotechnology company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels across a range of genetic diseases, today announced the pricing of its initial public offering of 6,820,000 shares of its common stock at an initial public offering price of $11.00 per share. All of the shares are being offered by CAMP4. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses, are expected to be approximately $75.0

Lynrock to become the principal equity owner and take CalAmp private Continues to operate business as usual throughout this process Enhanced liquidity to invest in innovation to support customers' evolving needs IRVINE, Calif., June 03, 2024 (GLOBE NEWSWIRE) --  CalAmp (NASDAQ:CAMP), a connected intelligence company helping people and organizations improve operational performance with a data-driven solutions ecosystem, today announced that it has entered into a Restructuring Support Agreement ("RSA") with its principal secured lender, Lynrock Lake Master Fund LP ("Lynrock"), who will become the principal equity owner of CalAmp and take the Company private. In a strategi

IRVINE, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- CalAmp (NASDAQ:CAMP), a connected intelligence company helping people and organizations improve operational performance with a data-driven solutions ecosystem, proudly announces the launch of Dispatch Monitor. This innovative application seamlessly integrates with the CalAmp K-12 suite of application solutions, fortifying CalAmp's commitment to improving school bus fleet management. Dispatch Monitor provides school districts with a comprehensive and real-time view of route coverage, ensuring efficient operations and optimized driver performance. By offering a consolidated snapshot of critical data points, including drivers' clock-in status,

IRVINE, Calif., Feb. 27, 2024 (GLOBE NEWSWIRE) -- CalAmp (NASDAQ:CAMP), a connected intelligence company helping people and organizations improve operational performance with a data-driven solutions ecosystem, today announced that on February 5, 2024, the Human Capital Committee of CalAmp's Board of Directors granted inducement restricted and performance stock unit awards covering 65,218 shares of CalAmp common stock to its Chief Executive Officer. The awards were granted under CalAmp's 2023 Employment Inducement Incentive Award Plan, which was adopted on August 15, 2023 and provides for the granting of equity awards to new employees of CalAmp. The restricted stock unit awards vest

IRVINE, Calif., Jan. 09, 2024 (GLOBE NEWSWIRE) -- CalAmp (NASDAQ:CAMP), a connected intelligence company that helps organizations monitor, track and protect their vital assets, today reported financial results for its third quarter of fiscal year 2024 ended November 30, 2023. Third Quarter Fiscal Year 2024 Financial Overview    Revenue was $53.6 million, representing a 13% decline QoQ and a 32% decline YoY driven primarily by softer demand in the TSP market segment.Gross margin was 33%, representing a decline of approximately 340 bps QoQ and 100 bps decline YoY as a result of a shift in product mix and a higher-than-normal reserve for excess and obsolete inventory.S&SS revenue was $34.5

CAMBRIDGE, Mass., Dec. 10, 2024 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation ("CAMP4") (NASDAQ:CAMP), a clinical-stage biotechnology company developing a pipeline of regRNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels across a range of genetic diseases, today announced the appointments of John Maraganore, Ph.D., and Rachel Meyers, Ph.D., as strategic advisors to the Company. For nearly 20 years, Dr. Maraganore served as the founding Chief Executive Officer and Director of Alnylam where he led the company's programs in RNA interference through global commercialization, resulting in the launch of the first four RNAi th

IRVINE, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- CalAmp (NASDAQ:CAMP), a connected intelligence company helping people and organizations improve operational performance with telematics solutions, is pleased to announce that Chris Adams will be joining the company as President and Chief Executive Officer (CEO), effective January 22, 2024. Adams is an accomplished technology leader who brings a wealth of knowledge and experience to CalAmp. He possesses a unique combination of technical depth, operational skills, and general management experience from a broad range of technology companies – most recently as VP/GM of the Automotive Sensing Division at onsemi. "After a comprehensiv

IRVINE, Calif., May 11, 2023 (GLOBE NEWSWIRE) -- CalAmp (NASDAQ:CAMP), a connected intelligence company helping people and organizations improve operational performance with a data-driven solutions ecosystem, today announced that Jeff Gardner will be stepping down from his role as Chief Executive Officer, effective no later than October 30, 2023. The Company has commenced a search for its next CEO and will be retaining an executive search firm. In announcing his departure, Jeff Gardner shared, "It has been a privilege working with the amazing group of colleagues at CalAmp. I am proud of all that we have accomplished and the progress we have made in positioning the Company for growth and p

IRVINE, Calif., Dec. 02, 2022 (GLOBE NEWSWIRE) -- CalAmp (NASDAQ:CAMP), a connected intelligence company that helps people and organizations improve operational performance, today announced that effective January 9, 2023, Jikun Kim, 58, will commence employment as Senior Vice President and Chief Financial Officer of CalAmp Corp. (the "Company"). Mr. Kim will serve as principal financial officer and principal accounting officer. Xiaolian (Cindy) Zhang will cease service as Interim Chief Financial Officer, and will continue to serve as Senior Vice President, Financial Planning and Analysis, and Erik Schulz will cease service as Interim Principal Accounting Officer, and will continue to serve

Mr. Cohenour brings 30+ years of executive leadership experience in IoT, mobile communications and semiconductors to Blackline Blackline Safety Corp. (TSX:BLN), a global leader in connected safety technology, today announced the appointment of Jason W. Cohenour, former President and CEO at Sierra Wireless, as a new member of its Board of Directors. Mr. Cohenour brings many years of executive leadership, sales, operations, and international M&A experience to the Blackline Safety Board. He previously served as President, CEO, and Director at Sierra Wireless, Inc. (TSX:SW, NASDAQ:SWIR) from 2005 to 2018. While CEO, Mr. Cohenour led a successful business turn-around, resulting in revenue gro

IRVINE, Calif., June 21, 2022 (GLOBE NEWSWIRE) -- CalAmp (NASDAQ:CAMP), a connected intelligence company helping people and organizations improve operational performance with a data-driven solutions ecosystem, today announced the appointment of Wes Cummins, Founder and Chief Executive Officer of B. Riley Asset Management, LLC ("BRAM"), to its Board of Directors (the "Board"), effective immediately. In connection with today's announcement, CalAmp has entered into a cooperation agreement with BRAM and one of its managed funds. "We are pleased to welcome Wes to the CalAmp Board, and believe his background as a technology investor and unique insight into our industry will bring valuable persp

IRVINE, Calif., May 23, 2022 (GLOBE NEWSWIRE) -- CalAmp (NASDAQ:CAMP), a connected intelligence company helping people and organizations improve operational performance with a data-driven solutions ecosystem, today announced the appointment of Brennen Carson as its chief revenue officer (CRO). As CRO, Carson will help accelerate CalAmp's penetration into the transportation and logistics marketplace and drive sustainable revenue streams. Carson brings over 15 years of experience in enterprise software-as-a-service (SaaS) sales, directing cross-functional small-to-medium-sized business, mid-market and enterprise teams to drive top-line revenue. Most recently, Carson served as senior vice pr

IRVINE, Calif., Jan. 27, 2022 /PRNewswire/ -- CalAmp (NASDAQ:CAMP), a connected intelligence company helping businesses and people track, monitor and recover vital assets with real-time visibility and insights, today announced the appointment of Mark Gaydos as its chief marketing officer (CMO). Gaydos will lead CalAmp's worldwide marketing strategy, go-to-market execution, branding and demand creation to help promote CalAmp's mission to automate and optimize transportation and logistics operations with its wide array of leading connected intelligence solutions. Gaydos brings more than 25 years of enterprise software marketing experience helping numerous technology companies build leadership

IRVINE, Calif., Jan. 4, 2022 /PRNewswire/ -- CalAmp (NASDAQ:CAMP), a connected intelligence company helping businesses and people track, monitor and recover vital assets with real-time visibility and insights, today announced the appointment of Basudeb Chatterjee to Chief Digital Information Officer (CDIO). As CDIO, Chatterjee will oversee CalAmp's global IT function with a focus on data, infrastructure and information security across all business units in North America, EMEA and LATAM. He will also guide technology adoption and enablement as part of transformation initiatives to strengthen the capabilities and value of CalAmp's connected intelligence solutions for fleet visibility and manag

IRVINE, Calif., July 13, 2021 /PRNewswire/ -- CalAmp (NASDAQ:CAMP), a connected intelligence company helping businesses and people track, monitor and recover vital assets with real-time visibility and insights, has appointed Richard Scott to senior vice president, general counsel and secretary. In this role, Scott will oversee CalAmp's global legal affairs, compliance, corporate governance and secretarial functions. He brings over 25 years of experience in contracts, intellectual property, mergers and acquisitions across multiple verticals including technology, energy and transportation. Scott has served both public and private companies in North America, South America, the Middle East and a